3-[5-(Aminomethyl)pyrimidin-2-yl]-1,3-oxazinan-2-one hydrochloride, 1g

(2E)-1-(4-ethylphenyl)-3-[4-(propan-2-yl)phenyl]prop-2-en-1-one, 95.0%, 2g

1-(3-Hydroxy-2-nitrophenyl)ethanone, 95.0%, 25g

1-Methyl-1H-pyrazole-5-carboxylic acid methyl ester, 95.0%, 100g

trans,trans-4'-Pentyl-4-(3,4,5-trifluorophenyl)bicyclohexyl>98.0%(GC)5g

1-Methyl-1-phenylurea, 95%, 1g

4-Chloro-1,8-naphthyridine, 95.0%, 1g

Methyl 3-Bromo-2-oxo-2H-pyran-5-carboxylate, 95.0%, 1g

2-Aminophenylacetylene, 98.0%, 1g

4'-Propylacetophenone>95.0%(GC)25g

n-[3-(aminomethyl)phenyl]benzamide hydrochloride, 95%, 500mg

Colonne capillaire GC ROTI®Cap-1701 MS, 60 m, 0,25 mm, 0,50 µm, 1 pièce(s)

Methyl 2-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate, 95.0%, 1g